Stanford University
Showing 161-170 of 204 Results
-
Sharon Sha, MD, MS
Clinical Professor, Adult Neurology
BioDr. Sha is a Clinical Professor of Neurology and Neurological Sciences at Stanford University where she serves as Chief for the Memory Disorders Division and the Stanford Memory Disorders Center, Associate Vice Chair of Clinical Research, Director of the Huntington’s Disease Center of Excellence and Ataxia Clinic, Co-Director of the Lewy Body Disease Association Research Center of Excellence, and Clinical Core Co-Leader of the Stanford Alzheimer's Disease Research Center. Her clinical time is devoted to caring for patients with Alzheimer’s disease and other neurodegenerative disorders and her research is devoted to finding treatments for these cognitive disorders. She also served on the California Governor’s Alzheimer’s Prevention and Preparedness Task Force Chaired by Maria Shriver in 2020. She has been featured in international media and documentaries such as the BBC "How to Stay Young" and the Docuseries "Limitless with Chris Hemsworth".
-
Mehrdad Shamloo
Professor (Research) of Neurosurgery and, by courtesy, of Neurology and Neurological Sciences
Current Research and Scholarly InterestsThe ultimate goal of the Shamloo laboratory is to rapidly advance our understanding of brain function at the molecular, cellular, circuit and behavioral levels, and to elucidate the pathological process underlying malfunction of the nervous system following injury and neurologic disorders such as stroke, Alzheimer's disease, Parkinson’s disease, and autism. We have been focusing on the noradrenergic system and approaches leading to restoration of brain adrenergic signaling in these disorders.
-
Irina Skylar-Scott
Clinical Assistant Professor, Adult Neurology
BioDr. Skylar-Scott is a board-certified, fellowship-trained cognitive and behavioral neurologist and clinical assistant professor at Stanford University. She is a Diplomate of the American Board of Psychiatry and Neurology as well as the United Council for Neurologic Subspecialties in Behavioral Neurology and Neuropsychiatry.
Her clinical interests include the treatment of cognitive and behavioral impairment due to Alzheimer’s disease, Parkinson’s disease, Lewy body dementia, posterior cortical atrophy, primary progressive aphasia, frontotemporal dementia, vascular dementia, primary age-related tauopathy, and limbic-predominant age-associated TDP-43 encephalopathy, among other disorders of cognition and behavior.
Her research interests include clinical trials for Alzheimer’s disease and how social and intellectual engagement can affect cognition. She has also investigated impaired consciousness in epilepsy and biomarkers for assessing Duchenne muscular dystrophy. Prior to joining Stanford, Dr. Skylar-Scott was a fellow in the Center for Alzheimer’s Research and Treatment (CART) in the Department of Neurology at Harvard Medical School/Brigham and Women’s Hospital. She also completed her undergraduate degree at MIT, her MD at Yale, and her residency at Harvard.
Dr. Skylar-Scott’s work has appeared in Neurology, Alzheimer's Research and Therapy, Pediatric Neurology, the Journal of Ultrasound in Medicine, Muscle & Nerve, and Epilepsia. She also has also been invited to write book chapters on Alzheimer’s disease, normal pressure hydrocephalus, Parkinson’s disease dementia and Lewy body dementia, and the cognitive and psychiatric consequences of neuroimmunological disorders published by Elsevier and McGraw-Hill.
Presentations by Dr. Skylar-Scott have focused on prevention of cognitive decline in at-risk elderly people, cognitive and neuropsychiatric manifestations of Parkinson’s disease, human prion diseases, and other topics. She has presented at meetings held by the American Academy of Neurology (AAN), the American Neurological Association (ANA), and the American Academy of Neuromuscular and Electrodiagnostic Medicine (AANEM).
For her research and scholarship, Dr. Skylar-Scott has earned honors from the American Academy of Neurology (AAN) and the Howard Hughes Medical Institute (HHMI). She was honored to receive the Golseth Young Investigator Award from the American Association of Neuromuscular & Electrodiagnostic Medicine. In addition, she won the Action Duchenne International Conference First Prize Poster for her research in Duchenne muscular dystrophy.
Dr. Skylar-Scott is a member of the American Neurological Association and American Academy of Neurology. Every year, she walks to raise money for Alzheimer's disease and Lewy body dementia. -
Yuen So, MD, PhD
Professor of Neurology and Neurological Sciences (Adult Neurology), Emeritus
Current Research and Scholarly InterestsResearch in the diagnosis, pathophysiology and treatment of peripheral neuropathy, myasthenia gravis, motor neuron diseases including ALS and SMA, nerve injuries and muscle diseases. Application of clinical neurophysiological methods to neurological diagnosis. Development of evidence-based medicine pertaining to the practice of neurology.
-
Kristen K. Steenerson, MD
Clinical Associate Professor, Otolaryngology (Head and Neck Surgery)
Clinical Assistant Professor, Adult NeurologyBio=Dr. Kristen K. Steenerson is a Clinical Associate Professor at Stanford University School of Medicine, specializing in vestibular neurology and neuro-otology. She directs clinical care within the Vestibular Neurology Clinic at the Stanford Ear Institute, where she focuses on the diagnosis and management of complex dizziness and balance disorders, including vestibular migraine, benign paroxysmal positional vertigo, Ménière disease, bilateral vestibulopathy, and persistent postural-perceptual dizziness.
Her academic program integrates translational research with clinician education to improve the diagnosis and treatment of vestibular disorders. Her research focuses on the development and validation of objective, technology-enabled tools to measure vestibular function in real-world settings. She leads initiatives evaluating wearable electro-oculography platforms for ambulatory nystagmus detection, as well as sensor-based systems using inertial measurement units to assess mobility, fall risk, and functional engagement. Her work leverages multidisciplinary collaboration across neurology, otolaryngology, audiology, engineering, and data science, with the goal of establishing scalable digital biomarkers and vestibular-specific clinical trial endpoints.
In parallel, Dr. Steenerson is deeply engaged in national and international clinician education. She serves as course director and faculty for multiple continuing medical education programs in vestibular neurology and neuro-otology, with a focus on bedside examination skills, acute dizziness evaluation, and diagnostic reasoning. She has developed interdisciplinary curricula and clinical training pathways designed to expand vestibular expertise among neurologists, otolaryngologists, advanced practice providers, and trainees.
Her scholarly work also includes clinical outcomes research and care delivery innovation, particularly in vestibular migraine and episodic vertigo disorders. She has led initiatives to standardize triage, referral pathways, and multidisciplinary care models for patients with dizziness, translating evidence into practical frameworks that improve access, diagnostic accuracy, and patient outcomes.
Through the integration of clinical innovation, translational research, and clinician education, Dr. Steenerson’s work aims to modernize vestibular care and expand the reach of specialized expertise beyond tertiary referral centers.
